Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Diabetic Macular Edema
1.2.5 Uveitis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Biologics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Biologics Market Perspective (2018-2033)
2.2 Retinal Biologics Growth Trends by Region
2.2.1 Global Retinal Biologics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Retinal Biologics Historic Market Size by Region (2018-2023)
2.2.3 Retinal Biologics Forecasted Market Size by Region (2024-2033)
2.3 Retinal Biologics Market Dynamics
2.3.1 Retinal Biologics Industry Trends
2.3.2 Retinal Biologics Market Drivers
2.3.3 Retinal Biologics Market Challenges
2.3.4 Retinal Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Biologics Players by Revenue
3.1.1 Global Top Retinal Biologics Players by Revenue (2018-2023)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Biologics Revenue
3.4 Global Retinal Biologics Market Concentration Ratio
3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2022
3.5 Retinal Biologics Key Players Head office and Area Served
3.6 Key Players Retinal Biologics Product Solution and Service
3.7 Date of Enter into Retinal Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Biologics Breakdown Data by Type
4.1 Global Retinal Biologics Historic Market Size by Type (2018-2023)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2024-2033)
5 Retinal Biologics Breakdown Data by Application
5.1 Global Retinal Biologics Historic Market Size by Application (2018-2023)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Retinal Biologics Market Size (2018-2033)
6.2 North America Retinal Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Retinal Biologics Market Size by Country (2018-2023)
6.4 North America Retinal Biologics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retinal Biologics Market Size (2018-2033)
7.2 Europe Retinal Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Retinal Biologics Market Size by Country (2018-2023)
7.4 Europe Retinal Biologics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Biologics Market Size (2018-2033)
8.2 Asia-Pacific Retinal Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Retinal Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Retinal Biologics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retinal Biologics Market Size (2018-2033)
9.2 Latin America Retinal Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Retinal Biologics Market Size by Country (2018-2023)
9.4 Latin America Retinal Biologics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Biologics Market Size (2018-2033)
10.2 Middle East & Africa Retinal Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Retinal Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Retinal Biologics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Spark Therapeutics, Inc
11.1.1 Spark Therapeutics, Inc Company Detail
11.1.2 Spark Therapeutics, Inc Business Overview
11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2018-2023)
11.1.5 Spark Therapeutics, Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Regeneron Pharmaceuticals, Inc Company Detail
11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2018-2023)
11.3.5 Regeneron Pharmaceuticals, Inc Recent Development
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Detail
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Retinal Biologics Introduction
11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2018-2023)
11.4.5 AbbVie Inc Recent Development
11.5 Johnson & Johnson Services, Inc
11.5.1 Johnson & Johnson Services, Inc Company Detail
11.5.2 Johnson & Johnson Services, Inc Business Overview
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2018-2023)
11.5.5 Johnson & Johnson Services, Inc Recent Development
11.6 Amgen Inc
11.6.1 Amgen Inc Company Detail
11.6.2 Amgen Inc Business Overview
11.6.3 Amgen Inc Retinal Biologics Introduction
11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2018-2023)
11.6.5 Amgen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Diabetic Macular Edema
Table 5. Key Players of Uveitis
Table 6. Key Players of Others
Table 7. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Retinal Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Retinal Biologics Market Share by Region (2018-2023)
Table 11. Global Retinal Biologics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Retinal Biologics Market Share by Region (2024-2033)
Table 13. Retinal Biologics Market Trends
Table 14. Retinal Biologics Market Drivers
Table 15. Retinal Biologics Market Challenges
Table 16. Retinal Biologics Market Restraints
Table 17. Global Retinal Biologics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Retinal Biologics Market Share by Players (2018-2023)
Table 19. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Table 20. Ranking of Global Top Retinal Biologics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Biologics Product Solution and Service
Table 24. Date of Enter into Retinal Biologics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Retinal Biologics Revenue Market Share by Type (2018-2023)
Table 28. Global Retinal Biologics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Retinal Biologics Revenue Market Share by Type (2024-2033)
Table 30. Global Retinal Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Retinal Biologics Revenue Market Share by Application (2018-2023)
Table 32. Global Retinal Biologics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Retinal Biologics Revenue Market Share by Application (2024-2033)
Table 34. North America Retinal Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Retinal Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Retinal Biologics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Retinal Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Retinal Biologics Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Retinal Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Retinal Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Retinal Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Retinal Biologics Market Size by Country (2024-2033) & (US$ Million)
Table 49. Spark Therapeutics, Inc Company Detail
Table 50. Spark Therapeutics, Inc Business Overview
Table 51. Spark Therapeutics, Inc Retinal Biologics Product
Table 52. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 53. Spark Therapeutics, Inc Recent Development
Table 54. F. Hoffmann-La Roche Ltd Company Detail
Table 55. F. Hoffmann-La Roche Ltd Business Overview
Table 56. F. Hoffmann-La Roche Ltd Retinal Biologics Product
Table 57. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 58. F. Hoffmann-La Roche Ltd Recent Development
Table 59. Regeneron Pharmaceuticals, Inc Company Detail
Table 60. Regeneron Pharmaceuticals, Inc Business Overview
Table 61. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
Table 62. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 63. Regeneron Pharmaceuticals, Inc Recent Development
Table 64. AbbVie Inc Company Detail
Table 65. AbbVie Inc Business Overview
Table 66. AbbVie Inc Retinal Biologics Product
Table 67. AbbVie Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 68. AbbVie Inc Recent Development
Table 69. Johnson & Johnson Services, Inc Company Detail
Table 70. Johnson & Johnson Services, Inc Business Overview
Table 71. Johnson & Johnson Services, Inc Retinal Biologics Product
Table 72. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Services, Inc Recent Development
Table 74. Amgen Inc Company Detail
Table 75. Amgen Inc Business Overview
Table 76. Amgen Inc Retinal Biologics Product
Table 77. Amgen Inc Revenue in Retinal Biologics Business (2018-2023) & (US$ Million)
Table 78. Amgen Inc Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Retinal Biologics Market Share by Type: 2022 VS 2033
Figure 3. Macular Degeneration Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Diabetic Macular Edema Features
Figure 6. Uveitis Features
Figure 7. Others Features
Figure 8. Global Retinal Biologics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Retinal Biologics Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Retinal Biologics Report Years Considered
Figure 14. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Retinal Biologics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Retinal Biologics Market Share by Region: 2022 VS 2033
Figure 17. Global Retinal Biologics Market Share by Players in 2022
Figure 18. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Biologics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2022
Figure 20. North America Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Retinal Biologics Market Share by Country (2018-2033)
Figure 22. United States Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Retinal Biologics Market Share by Country (2018-2033)
Figure 26. Germany Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Retinal Biologics Market Share by Region (2018-2033)
Figure 34. China Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Retinal Biologics Market Share by Country (2018-2033)
Figure 42. Mexico Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Retinal Biologics Market Share by Country (2018-2033)
Figure 46. Turkey Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Retinal Biologics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 50. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 51. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 52. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 53. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed